Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 458 of 641 · 7,691 filings

  • Orasure Technologies (OSUR) FY2024 10-K risk factors
    68 risks

    The company relies heavily on genomics, COVID-19 testing revenues, and specific government contracts.

    Filed Mar 07, 2025
  • Profound Medical (PROF) FY2024 10-K risk factors
    66 risks

    Profound Medical operates with high capital requirements and faces extensive regulatory oversight for its medical devices. Commercial success heavily depends on third-party MRI compatibility and hospital sales channels. Operations face single-source supply chain risks and complex international compliance burdens.

    Filed Mar 07, 2025
  • Rigetti Computing (RGTI) FY2024 10-K risk factors
    65 risks

    Rigetti faces substantial operating losses, heavy reliance on U.S. government contracts, and significant engineering hurdles in commercializing quantum computing.

    Filed Mar 07, 2025
  • SB Financial Group (SBFG) FY2024 10-K risk factors
    37 risks

    SBFG faces primary risks from economic fluctuations, cybersecurity vulnerabilities, intense banking competition, and heavy regulatory oversight.

    Filed Mar 07, 2025
  • Sight Sciences (SGHT) FY2024 10-K risk factors
    54 risks

    Sight Sciences faces ongoing significant net losses with an accumulated deficit of $346.3 million as of December 31, 2024. The business relies heavily on the commercial success and adoption of its OMNI and TearCare products. Heavy reliance on debt financing, including a $65.0 million Hercules Loan Agreement, creates operational constraints.

    Filed Mar 07, 2025
  • Surgery Partners (SGRY) FY2024 10-K risk factors
    43 risks

    The company faces heavy concentration risk in Idaho and high reliance on government and private payors. Substantial debt and net operating losses create severe financial pressures. Strict healthcare regulations and compliance demands threaten operations and revenues.

    Filed Mar 07, 2025
  • South Plains Financial (SPFI) FY2024 10-K risk factors
    63 risks

    South Plains Financial is highly concentrated in commercial and real estate lending across Texas and New Mexico.

    Filed Mar 07, 2025
  • Theravance Biopharma (TBPH) FY2024 10-K risk factors
    53 risks

    Theravance Biopharma faces concentrated revenue risk tied to YUPELRI sales and partnership performance with Viatris and Royalty Pharma. The company relies on continuous clinical development, single-source manufacturing, and navigating extensive regulatory and healthcare pricing frameworks. A Strategic Review Committee was formed in November 2024 to unlock shareholder value.

    Filed Mar 07, 2025
  • Teads Holding (TEAD) FY2024 10-K risk factors
    62 risks

    Teads Holding faces severe business risks centered around its recent acquisition by Outbrain, heavy reliance on digital advertising revenues, and operational dependencies in Israel.

    Filed Mar 07, 2025
  • Alpha Teknova (TKNO) FY2024 10-K risk factors
    79 risks

    Operating losses of $26.7 million in 2024 dominate financial risks for Alpha Teknova, driven by customer spending, regulatory compliance, and manufacturing execution.

    Filed Mar 07, 2025
  • LendingTree (TREE) FY2024 10-K risk factors
    55 risks

    Mortgage and interest rate volatility heavily impact network partner performance and lead generation volume. High revenue concentration in two network partners creates significant operational vulnerability. Substantial accumulated deficit, ongoing operating losses, and strict debt covenants threaten financial stability.

    Filed Mar 07, 2025
  • Mammoth Energy Services (TUSK) FY2024 10-K risk factors
    67 risks

    Mammoth Energy Services relies on concentrated oilfield and infrastructure customers, revolving credit restrictions, and fluctuating commodity prices. Operations face severe weather vulnerabilities across U.S. and Canadian resource plays alongside capital expenditure constraints.

    Filed Mar 07, 2025

Companies covered

4,011 companies

371 more under A